Join to view full profile
1959 NE Pacific StSeattle, WA 98195
Phone+1 206-520-5000
Dr. Bjornstad is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of ColoradoFellowship, Pediatric Endocrinology, 2015 - 2018- University of ColoradoResidency, Pediatrics, 2012 - 2015
Royal College of Surgeons IrelandClass of 2010
Certifications & Licensure
WA State Medical License 2023 - 2028
CO State Medical License 2015 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Endocrinology
Clinical Trials
- Effect of Urinary Alkalinization on Urine Uric Acid Precipitation and Crystallization in Adults With Type 1 Diabetes
- Diabetic Kidney Alarm (DKA) Study Start of enrollment: 2017 Jun 01
- Renal HEIR Study: Renal Hemodynamics, Energetics and Insulin Resistance in Youth Onset Type 2 Diabetes Study Start of enrollment: 2018 Oct 01
Publications & Presentations
PubMed
- Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.Virginia Bellido, Carel W le Roux, Elif I Ekinci, Petter Bjornstad, Juan P Frias
Lancet. 2026-10-10 - Phenotypes of diabetic kidney disease and cardiovascular outcomes.Sophie E Claudel, Runqi Zhao, Insa M Schmidt, Petter Bjornstad, Anand Srivastava
European Journal of Internal Medicine. 2026-10-08 - 1 citationsASN Kidney Health Guidance on the Cardiovascular-Kidney-Metabolic Syndrome.Nisha Bansal, Petter Bjornstad, Adam P Bress, Tara I Chang, Xingxing Cheng
Journal of the American Society of Nephrology. 2026-10-01
Authored Content
- ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
- ADA 2018: Dr. Petter Bjornstad on Adioposity, Insulin Resistance and Type 2 Diabetes MellitusJuly 2018
- Acute Effect of Empagliflozin on Fractional Excretion of Sodium and eGFR in Youth with Type 2 DiabetesJune 2018
Press Mentions
- Parkinson's Medication Improved Blood Pressure in Teens with Type 1 DiabetesDecember 6th, 2022
- CU School of Medicine Researcher Brews up Study on Coffee’s Effects on Acute Kidney InjurySeptember 23rd, 2022
- SGLT2 Inhibitors Breathe Life into Kidney-Disease CareAugust 10th, 2022
Grant Support
- Metabolite Markers of Diabetic Kidney DiseaseUNIVERSITY OF TEXAS HLTH SCIENCE CENTER2026–2031
- Pubertal Kidney Injury in Diabetes: Phenotypes, Biomarkers, TrajectoriesSEATTLE CHILDREN'S HOSPITAL2021–2031
- Pubertal Kidney Injury in Diabetes: Phenotypes, Biomarkers, TrajectoriesSEATTLE CHILDREN'S HOSPITAL2021–2031
- KPMP in Type 1 Diabetes: A UW Medicine CollaborationUNIVERSITY OF WASHINGTON2025–2030
- Advancing ADPKD Treatment with GLP-1RA: A Study of Glucagon-Like Peptide-1 Receptor Agonists' Efficacy, Safety, and MechanismUNIVERSITY OF COLORADO DENVER2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: